Indian Immunoglobulin Exporters: Complete Supplier Ranking with Market Share — 570 Manufacturers (2026) — TransData Nexus

Q: Who is the largest immunoglobulin buyer importing from India?

STATE PHARMACEUTICALS CORPORATION (SRI LANKA) is the largest immunoglobulin importer from India with a 8.6% market share and import value of $15.5M.

Q: How many immunoglobulin buyers import from India?

There are 570 active immunoglobulin buyers importing from India, with a combined import market of $180.0M across 1,841 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top immunoglobulin buyers from India?

The top 5 immunoglobulin buyers — STATE PHARMACEUTICALS CORPORATION, AMBICA INTERNATIONAL CORPORATION, STATE PHARMACEUTICALS CORPORATION O, LIBRA CHILE S.A, DROGUERIA MK LAB S.A.C — together control 27.1% of total immunoglobulin import value from India.

Suresh Sormare

Immunoglobulin

India Pharmaceutical Trade Intelligence

$180.0M197 Suppliers119 CountriesHS 30021290

ExportsIndia → SRI LANKA15.5%India → UNITED ARAB13.7%

ImportsUNITED STATES → India$48.2B FRANCE → India$25.3B

#1 Supplier: RELIANCE LIFE #1 Buyer: STATE PHARMACEUTICALS

Market Analysis: Top Importing Countries & Their Importers

1Sri Lanka

Sri Lanka emerges as the first largest importing country, achieving a total trade value of $27.9M through 21 shipments. This represents a market share of 15.5% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: Sri Lanka has a diverse importer base, with their top importers including:

• STATE PHARMACEUTICALS CORPORATION - $15.5M (55.5% of country's total business)

• STATE PHARMACEUTICALS CORPORATION O - $7.8M (28.0% of country's total business)

Key Insight: Sri Lanka demonstrates strong market positioning with an average shipment value of $1.3M, indicating premium pricing strategy compared to the market average of $97.8K.

Sri Lanka is a key market for Immunoglobulin imports, representing 15.5% of total trade value.

Primary Market

Secondary Market

2United Arab Emirates

United Arab Emirates emerges as the second largest importing country, achieving a total trade value of $24.7M through 24 shipments. This represents a market share of of the total market activity, demonstrating their significant presence in the industry.

Buyer Segment Analysis

TransData Nexus Immunoglobulin buyer market intelligence

1Buyer Segment Analysis

The importation of Immunoglobulin from India involves various buyer segments, each with distinct purchasing behaviors and order patterns.

Government Procurement Agencies: Entities like the State Pharmaceuticals Corporation (Sri Lanka) and Seguro Social de Salud del (Peru) fall into this category. These agencies typically procure large volumes through national tenders to supply public healthcare facilities. Their purchasing is characterized by bulk orders, often aligned with government budgets and healthcare programs, ensuring consistent supply to meet public health demands.

Distributors: Companies such as Ambica International Corporation (Philippines) and Libra Chile S.A (Chile) act as intermediaries, sourcing Immunoglobulin to supply hospitals, clinics, and pharmacies. Their order patterns are influenced by market demand, and they often maintain inventory to ensure timely delivery to healthcare providers.

Re-exporters: Firms like Peace World General Trading LLC (United Arab Emirates) and Lazerhead Capital Ltd (United Arab Emirates) may import Immunoglobulin with the intent to re-export to neighboring regions. Their purchasing behavior is driven by regional demand fluctuations and opportunities in adjacent markets.

Hospital Groups and Retail Chains: While not explicitly listed among the top buyers, these entities typically procure Immunoglobulin directly from manufacturers or through distributors to meet the needs of their patients. Their order patterns are generally consistent, based on patient requirements and treatment protocols.

Contract Manufacturers: These are companies that produce Immunoglobulin on behalf of other firms. They may import raw materials or finished products to fulfill contractual obligations. Their purchasing is project-based and varies according to contractual agreements.

Country-Specific Import Regulations

TransData Nexus Immunoglobulin buyer market intelligence

1Country-Specific Import Regulations

Sri Lanka:

1. Drug Regulatory Authority: National Medicines Regulatory Authority (NMRA).

2. Import Registration Process: Importers must obtain an import license from the NMRA, which involves submitting detailed product information, including quality standards and manufacturing practices.

3. Estimated Timeline for Registration: The registration process typically takes 3 to 6 months, depending on the completeness of the application and any required inspections.

4. Import Tariff/Duty for HS 30021290: Under the Indo-Sri Lanka Free Trade Agreement (ISFTA), certain pharmaceutical products may be exempt from customs duties. Importers should consult the latest tariff schedules to confirm applicable duties. (customs.gov.lk)

United Arab Emirates (UAE):

1. Drug Regulatory Authority: Ministry of Health and Prevention (MOHAP).

2. Import Registration Process: Importers are required to register pharmaceutical products with MOHAP, providing comprehensive documentation on product efficacy, safety, and quality.

3. Estimated Timeline for Registration: The registration process can take approximately 6 to 12 months, subject to the review process and any additional information requests.

4. Import Tariff/Duty for HS 30021290: Pharmaceutical products are generally exempt from import duties in the UAE; however, importers should verify current regulations to ensure compliance.

Colombia:

1. Drug Regulatory Authority: National Institute for Food and Drug Surveillance (INVIMA).

2. Import Registration Process: Importers must register pharmaceutical products with INVIMA, submitting detailed dossiers that include clinical data and manufacturing information.

Demand Drivers & Market Opportunity

TransData Nexus Immunoglobulin buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Immunoglobulin in importing countries is driven by several key factors:

1. Disease Prevalence: Immunoglobulin is essential in treating primary immunodeficiency disorders and certain autoimmune diseases. The prevalence of these conditions necessitates a steady supply of Immunoglobulin to manage patient health effectively.

2. Government Healthcare Programs: Many countries have implemented healthcare programs aimed at improving access to essential medicines. For instance, the World Health Organization (WHO) emphasizes the importance of including essential medicines in national procurement lists to ensure availability. (iris.who.int)

3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased procurement of essential medicines, including Immunoglobulin, to meet the healthcare needs of the population.

4. WHO Essential Medicines List Procurement: Inclusion of Immunoglobulin in the WHO Essential Medicines List encourages countries to prioritize its procurement, ensuring that patients have access to necessary treatments.

5. Tender-Based Purchasing: Many governments and healthcare institutions utilize tender-based procurement systems to acquire medicines. This approach can lead to competitive pricing and reliable supply chains for Immunoglobulin.

With 570 buyers across 119 countries, the global market for Immunoglobulin presents significant opportunities. Understanding the specific demand drivers in each region can aid suppliers in effectively meeting market needs and expanding their reach.

TransData Nexus Research · Government and regulatory sources

Common Questions — Immunoglobulin Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest immunoglobulin buyer importing from India?

Based on import volume and value, STATE PHARMACEUTICALS CORPORATION (SRI LANKA) leads with $15.5M in imports and a 8.6% market share — the highest of any single immunoglobulin importer. AMBICA INTERNATIONAL CORPORATION (PHILIPPINES) and STATE PHARMACEUTICALS CORPORATION O (SRI LANKA) are the next largest buyers.

QHow many companies buy immunoglobulin from India?

There are 570 active immunoglobulin buyers importing from India, with a combined market of $180.0M across 1,841 shipments to 119 countries. The top 5 buyers hold 27.1% of total import value, while the remaining 565 buyers handle the other 72.9%.

QWhich countries import the most immunoglobulin from India?

The top importing countries for immunoglobulin from India are Sri Lanka (15.5%), United Arab Emirates (13.7%), Colombia (11.0%), Peru (10.0%), Philippines (9.8%). These markets represent the largest demand centres for Indian pharmaceutical exports of immunoglobulin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for immunoglobulin from India?

The average import transaction value for immunoglobulin from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Immunoglobulin buyer market intelligence

1Buyer Segment Analysis

The importation of Immunoglobulin from India involves various buyer segments, each with distinct purchasing behaviors and order patterns.

Country-Specific Import Regulations

TransData Nexus Immunoglobulin buyer market intelligence

1Country-Specific Import Regulations

Sri Lanka:

1. Drug Regulatory Authority: National Medicines Regulatory Authority (NMRA).

2. Import Registration Process: Importers must obtain an import license from the NMRA, which involves submitting detailed product information, including quality standards and manufacturing practices.

3. Estimated Timeline for Registration: The registration process typically takes 3 to 6 months, depending on the completeness of the application and any required inspections.

United Arab Emirates (UAE):

1. Drug Regulatory Authority: Ministry of Health and Prevention (MOHAP).

2. Import Registration Process: Importers are required to register pharmaceutical products with MOHAP, providing comprehensive documentation on product efficacy, safety, and quality.

3. Estimated Timeline for Registration: The registration process can take approximately 6 to 12 months, subject to the review process and any additional information requests.

4. Import Tariff/Duty for HS 30021290: Pharmaceutical products are generally exempt from import duties in the UAE; however, importers should verify current regulations to ensure compliance.

Colombia:

1. Drug Regulatory Authority: National Institute for Food and Drug Surveillance (INVIMA).

2. Import Registration Process: Importers must register pharmaceutical products with INVIMA, submitting detailed dossiers that include clinical data and manufacturing information.

Demand Drivers & Market Opportunity

TransData Nexus Immunoglobulin buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Immunoglobulin in importing countries is driven by several key factors:

TransData Nexus Research · Government and regulatory sources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Immunoglobulin

Immunoglobulin

Who Buys Immunoglobulin from India — 570 Importers Behind a $180.0M Market

Top Immunoglobulin Importers — Ranked by Import Value

Top Immunoglobulin Buyers & Importers

Related Analysis

Need Details?

Market Analysis: Top Importing Countries & Importers

Which companies are buying Immunoglobulin — and from which countries?

Immunoglobulin — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1Sri Lanka

2United Arab Emirates

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Immunoglobulin Buyers & Importers

QWho is the largest immunoglobulin buyer importing from India?

QHow many companies buy immunoglobulin from India?

QWhich countries import the most immunoglobulin from India?

QWhat is the average import order value for immunoglobulin from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Colombia

4Peru

5Philippines

Analysis Methodology